(1)
Qi, Y.-B.; Li, X.-T.; Shao, Q.-Q.; Xu, L.; Zhang, W.-J.; Song, S.-B.; Yan, Q.-N.; Shi, S.-Y.; Hu, R.-B.; Mekky, A.; Zhang, C.; Ma, J.; Xiao, W.; Li, K.; Liu, T.-T.; Fang, X.-H.; Zhang, L.-D.; Yang, G.-H.; Ding, S.-Z. Vonoprazan-Containing Dual and Triple Therapies Are Non-Inferior to Bismuth-Quadruple Therapy for Helicobacter Pylori Eradication: A Single-Center, Prospective, Open-Label, Real-World Study. JGLD 2025, 34, 295-303.